The Effective Effect-Site Propofol Concentration for Induction and Intubation with Two Pharmacokinetic Models in Morbidly Obese Patients Using Total Body Weight
Loading...
Date
2012
Journal Title
Journal ISSN
Volume Title
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Abstract
BACKGROUND: Most pharmacokinetic (PK) models used for propofol administration are based on studies in normal-weight patients. Extrapolation of these models for morbidly obese patients is controversial. Using 2 PK models and a target-controlled infusion system, we determined the predicted propofol effect-site concentration (Ce) needed for induction of anesthesia in morbidly obese subjects using total body weight.
METHODS: Sixty-six morbidly obese subjects from 18 to 50 years of age were randomized to receive propofol to reach and maintain a predetermined propofol Ce, based on the PK models of either Marsh or Schnider. All patients were monitored with a Bispectral Index electroencephalographic monitor. Fentanyl 3 mu g/kg total body weight was administered before starting the propofol infusion. After loss of consciousness, vecuronium was, administered to facilitate endotracheal intubation. Groups of 6 patients each received propofol at a different, predetermined target propofol Ce. An "effective Ce" (ECe) was defined as the propofol Ce that provided adequate hypnosis (Bispectral Index <60) during the complete induction period (45 seconds after reaching the predetermined target Ce until 5 minutes after tracheal intubation). Heart rate and arterial blood pressure were measured every 1 minute throughout the study period. Probit regression analysis was performed to calculate the effective propofol Ce values to induce hypnosis in 50% (ECe50) and 95% (ECe95) of patients with 95% confidence intervals (CIs).
RESULTS: Patient characteristics were similar between models and across the propofol target concentration groups. The ECe50 of propofol was 3.4 mu g/mL (95% CI: 2.9, 3.7 mu g/mL) with the Marsh model and 4.5 mu g/mL (95% CI: 4.1, 4.8 mu g/mL) with the Schnider model (P < 0.001). The ECe95 values were 4.2 mu g/mL (95% CI: 3.8, 6.2 mu g/mL) and 5.5 mu g/mL (95% CI: 5.0, 7.2 mu g/mL) with Marsh and Schnider models, respectively. At the ECe95, hemodynamic effects were similar with the 2 PK models.
CONCLUSION: Different propofol target concentrations for each PK model must be used for induction when using total body weight in morbidly obese patients. (Anesth Analg 2012;115: 823-9)
METHODS: Sixty-six morbidly obese subjects from 18 to 50 years of age were randomized to receive propofol to reach and maintain a predetermined propofol Ce, based on the PK models of either Marsh or Schnider. All patients were monitored with a Bispectral Index electroencephalographic monitor. Fentanyl 3 mu g/kg total body weight was administered before starting the propofol infusion. After loss of consciousness, vecuronium was, administered to facilitate endotracheal intubation. Groups of 6 patients each received propofol at a different, predetermined target propofol Ce. An "effective Ce" (ECe) was defined as the propofol Ce that provided adequate hypnosis (Bispectral Index <60) during the complete induction period (45 seconds after reaching the predetermined target Ce until 5 minutes after tracheal intubation). Heart rate and arterial blood pressure were measured every 1 minute throughout the study period. Probit regression analysis was performed to calculate the effective propofol Ce values to induce hypnosis in 50% (ECe50) and 95% (ECe95) of patients with 95% confidence intervals (CIs).
RESULTS: Patient characteristics were similar between models and across the propofol target concentration groups. The ECe50 of propofol was 3.4 mu g/mL (95% CI: 2.9, 3.7 mu g/mL) with the Marsh model and 4.5 mu g/mL (95% CI: 4.1, 4.8 mu g/mL) with the Schnider model (P < 0.001). The ECe95 values were 4.2 mu g/mL (95% CI: 3.8, 6.2 mu g/mL) and 5.5 mu g/mL (95% CI: 5.0, 7.2 mu g/mL) with Marsh and Schnider models, respectively. At the ECe95, hemodynamic effects were similar with the 2 PK models.
CONCLUSION: Different propofol target concentrations for each PK model must be used for induction when using total body weight in morbidly obese patients. (Anesth Analg 2012;115: 823-9)
Description
Keywords
INFUSION, ANESTHESIA, PHARMACODYNAMICS, CHILDREN, PLASMA